STING Agonist‐Loaded Nanoparticles Promotes Positive Regulation of Type I Interferon‐Dependent Radioimmunotherapy in Rectal Cancer
2023 · Advanced Science · 25 citations
https://doi.org/10.1002/advs.202307858
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
96
Citations
4
h-index
3
i10-index
Zhiwen Lin is an academic researcher from Guangdong Pharmaceutical University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Cancer, Hypoxia, and Metabolism & Nanoplatforms for cancer theranostics. The author has an h-index of 4, co-authored 5 publications.
Click to start Chat